Document is current
Any future updates will be listed below
-
Authors
Stuhldreier, Fabian
Schmitt, Laura https://orcid.org/0000-0003-0020-9800
Lenz, Thomas
Hinxlage, Ilka
Zimmermann, Marcel
Wollnitzke, Philipp
Schliehe-Diecks, Julian
Liu, Yang
Jäger, Paul
Geyh, Stefanie
Teusch, Nicole
Peter, Christoph https://orcid.org/0000-0002-0048-2279
Bhatia, Sanil https://orcid.org/0000-0001-6494-7744
Haas, Rainer
Levkau, Bodo
Reichert, Andreas S. https://orcid.org/0000-0001-9340-3113
Stühler, Kai
Proksch, Peter
Stork, Björn https://orcid.org/0000-0002-4167-7806
Wesselborg, Sebastian https://orcid.org/0000-0002-5236-942X
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (RTG 2578)
Deutsche Forschungsgemeinschaft (RTG 2158)
Deutsche Forschungsgemeinschaft (RTG 2158)
Deutsche Forschungsgemeinschaft (STO 864/4-3)
Deutsche Forschungsgemeinschaft (STO 864/5-1)
Deutsche Forschungsgemeinschaft (RTG 2578)
Deutsche Forschungsgemeinschaft (RTG 2578)
Deutsche Forschungsgemeinschaft (RTG 2158)
- License Information
-
More Information
Article History
Received: 11 April 2022
Revised: 30 September 2022
Accepted: 17 October 2022
First Online: 8 November 2022
Competing interests
: The authors declare no competing interests.
: The study of Peripheral blood mononuclear cells (PBMC) and hematopoietic stem and progenitor cells (HSPC) was approved by the local ethical review committee (study number: 5944 R; registration ID: 2017044215), and all patients gave written informed consent.
